Euro Pacific Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.2M | Buy |
213,261
+292
| +0.1% | +$11.2K | 1.32% | 25 |
|
|
2025
Q1 | $8.23M | Sell |
212,969
-1,196
| -0.6% | -$46.2K | 1.49% | 23 |
|
|
2024
Q4 | $7.23M | Sell |
214,165
-3,721
| -2% | -$126K | 1.56% | 26 |
|
|
2024
Q3 | $8.88M | Sell |
217,886
-3,336
| -2% | -$136K | 1.64% | 26 |
|
|
2024
Q2 | $8.55M | Sell |
221,222
-6,567
| -3% | -$254K | 1.69% | 26 |
|
|
2024
Q1 | $9.58M | Sell |
227,789
-6,327
| -3% | -$266K | 1.95% | 23 |
|
|
2023
Q4 | $8.74M | Buy |
234,116
+2,070
| +0.9% | +$77.3K | 1.87% | 26 |
|
|
2023
Q3 | $8.43M | Sell |
232,046
-1,664
| -0.7% | -$60.4K | 1.97% | 24 |
|
|
2023
Q2 | $8.17M | Buy |
233,710
+9,553
| +4% | +$334K | 1.79% | 26 |
|
|
2023
Q1 | $7.98M | Buy |
224,157
+1,302
| +0.6% | +$46.4K | 1.71% | 28 |
|
|
2022
Q4 | $7.76M | Buy |
222,855
+845
| +0.4% | +$29.4K | 1.74% | 27 |
|
|
2022
Q3 | $6.61M | Buy |
222,010
+15,944
| +8% | +$475K | 1.74% | 29 |
|
|
2022
Q2 | $11.1M | Buy |
206,066
+3,232
| +2% | +$174K | 2.62% | 16 |
|
|
2022
Q1 | $11.1M | Buy |
202,834
+17,052
| +9% | +$930K | 2.17% | 25 |
|
|
2021
Q4 | $10.2M | Buy |
185,782
+1,599
| +0.9% | +$87.5K | 2.29% | 22 |
|
|
2021
Q3 | $9.44M | Buy |
184,183
+15,727
| +9% | +$806K | 2.46% | 18 |
|
|
2021
Q2 | $8.39M | Buy |
168,456
+5,537
| +3% | +$276K | 2.04% | 23 |
|
|
2021
Q1 | $7.34M | Buy |
162,919
+7,209
| +5% | +$325K | 1.89% | 25 |
|
|
2020
Q4 | $7.26M | Buy |
155,710
+1,054
| +0.7% | +$49.2K | 1.76% | 25 |
|
|
2020
Q3 | $7.33M | Sell |
154,656
-546
| -0.4% | -$25.9K | 1.86% | 20 |
|
|
2020
Q2 | $7.96M | Sell |
155,202
-2,668
| -2% | -$137K | 2.22% | 19 |
|
|
2020
Q1 | $8.28M | Sell |
157,870
-120,721
| -43% | -$6.33M | 2.74% | 13 |
|
|
2019
Q4 | $16.4M | Buy |
+278,591
| New | +$16.4M | 5.91% | 3 |
|